4741 related articles for article (PubMed ID: 6401786)
1. 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase.
FitzGerald GB; Wick MM
J Invest Dermatol; 1983 Feb; 80(2):119-23. PubMed ID: 6401786
[TBL] [Abstract][Full Text] [Related]
2. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
Wick MM
Cancer Res; 1980 May; 40(5):1414-8. PubMed ID: 6768447
[TBL] [Abstract][Full Text] [Related]
3. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma.
Wick MM
J Natl Cancer Inst; 1979 Dec; 63(6):1465-7. PubMed ID: 292814
[TBL] [Abstract][Full Text] [Related]
4. Potentiation by alpha-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanoma.
Prakash NJ; Sunkara PS; Sjoerdsma A
Biochem Pharmacol; 1985 Jun; 34(11):1887-90. PubMed ID: 3924051
[TBL] [Abstract][Full Text] [Related]
5. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
Prezioso JA; Fitzgerald GB; Wick MM
Pigment Cell Res; 1990; 3(2):49-54. PubMed ID: 2117268
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of reverse transcriptase by tyrosinase generated quinones related to levodopa and dopamine.
Wick MM; Fitzgerald G
Chem Biol Interact; 1981 Dec; 38(1):99-107. PubMed ID: 6173137
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine.
FitzGerald GB; Wick MM
Biochem Pharmacol; 1985 Feb; 34(3):353-60. PubMed ID: 3882092
[TBL] [Abstract][Full Text] [Related]
8. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
Wick MM
Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
[TBL] [Abstract][Full Text] [Related]
9. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
Prezioso JA; FitzGerald GB; Wick MM
J Invest Dermatol; 1992 Sep; 99(3):289-93. PubMed ID: 1512464
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of L-glutamic acid dihydroxyanilides against experimental melanoma.
Wick MM; Rosowsky A; Ratliff J
J Invest Dermatol; 1980 Feb; 74(2):112-4. PubMed ID: 6766171
[TBL] [Abstract][Full Text] [Related]
11. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
Kable EP; Parsons PG
Cancer Chemother Pharmacol; 1989; 23(1):1-7. PubMed ID: 2909284
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA polymerase-alpha and -beta of calf thymus by 1-beta-D-arabinofuranosylcytosine-5'-triphosphate.
Yoshida S; Yamada M; Masaki S
Biochim Biophys Acta; 1977 Jul; 477(2):144-50. PubMed ID: 328050
[TBL] [Abstract][Full Text] [Related]
13. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo.
Wick MM
J Invest Dermatol; 1978 Aug; 71(2):163-4. PubMed ID: 681787
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of DNA polymerases of calf thymus by 9-beta-D-arabinofuranosyladenine-5'-triphosphate.
Okura A; Yoshida S
J Biochem; 1978 Sep; 84(3):727-32. PubMed ID: 82555
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase enhances the covalent modification of DNA by dopamine.
Stokes AH; Brown BG; Lee CK; Doolittle DJ; Vrana KE
Brain Res Mol Brain Res; 1996 Nov; 42(1):167-70. PubMed ID: 8915597
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA polymerase by captan.
Dillwith JW; Lewis RA
Biochim Biophys Acta; 1982 Mar; 696(3):245-52. PubMed ID: 7039680
[TBL] [Abstract][Full Text] [Related]
17. Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.
Wick MM
J Invest Dermatol; 1989 May; 92(5 Suppl):329S-331S. PubMed ID: 2715667
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of calf thymus DNA polymerase alpha and of normal and cancer cell growth by butylanilinouracil and butylphenylguanine.
Rochowska M; Siedlecki J; Skurzak H; Wright G; Zmudzka B
Biochim Biophys Acta; 1982 Oct; 699(1):67-73. PubMed ID: 6756479
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma.
FitzGerald GB; Wick MM
J Invest Dermatol; 1987 Jan; 88(1):66-70. PubMed ID: 2947954
[TBL] [Abstract][Full Text] [Related]
20. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
Prezioso JA; Damodaran KM; Wang N; Bloomer WD
Biochem Pharmacol; 1993 Jan; 45(2):473-81. PubMed ID: 8435097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
